Search
bevacizumab ophthalmic (Avastin)
Indications:
- diabetic macular edema
Dosage:
- intravitreal injection
Mechanism of action:
- VEGF inhibitor
Interactions
drug adverse effects of pharmaceutical monoclonal antibodies
General
bevacizumab (Avastin, Altuzan)
ophthalmic agent (eyedrops)
References
- The Diabetic Retinopathy Clinical Research Network.
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema.
N Engl J Med. 2015 Feb 18.
PMID: 25692915
http://www.nejm.org/doi/full/10.1056/NEJMoa1414264
- Martin DF, Maguire MG.
Treatment Choice for Diabetic Macular Edema.
N Engl J Med. 2015 Feb 18. [Epub ahead of print]
PMID: 25692914
http://www.nejm.org/doi/full/10.1056/NEJMe1500351